Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

about

Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Item

http://www.wikidata.org/entity/Q55401199

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Efficacy and Safety of Once-We ...... Randomized Controlled Trials.

@en

Efficacy and Safety of Once-We ...... Randomized Controlled Trials.

@nl

type

Item

label

Efficacy and Safety of Once-We ...... Randomized Controlled Trials.

@en

Efficacy and Safety of Once-We ...... Randomized Controlled Trials.

@nl

prefLabel

Efficacy and Safety of Once-We ...... Randomized Controlled Trials.

@en

Efficacy and Safety of Once-We ...... Randomized Controlled Trials.

@nl

P1476

Efficacy and Safety of Once-We ...... f Randomized Controlled Trials

@en

P2093

Fang-Hong Shi

http://www.w3.org/2001/XMLSchema#string

Min Cui

http://www.w3.org/2001/XMLSchema#string

Xiao-Yan Liu

http://www.w3.org/2001/XMLSchema#string

Zai-Li Zhang

http://www.w3.org/2001/XMLSchema#string

Zhi-Chun Gu

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies

Bias in meta-analysis detected by a simple, graphical test

Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysis

Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Efficacy and safety of dulaglutide in patients with type 2 diabetes: a meta-analysis and systematic review

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

P304

576

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.00576

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hao Li

P577

2018-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29915538

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

5994433

http://www.w3.org/2001/XMLSchema#string